Peyman Hosseinchi
Associate at Ra Ventures
San Diego Metropolitan Area
Overview
Work Experience
Senior Associate
2024 - Current
Associate
2023 - 2024
Company creation across modalities and therapeutic areas (e.g. oncology, immunology, cardiometabloic and rare disease) Responsibilities include ideating new concepts, developing pipeline/corporate strategies, R&D planning, developing investment theses and leading operational execution
Associate
2021 - 2023
Therapeutics investment; Led diligence to originate conviction in public and private biotechs ; Advised RA's portfolio on their target selection and pipeline strategy
RA Capital Management is an investment advisor specializing in the life-sciences and drug development sectors.
Postdoctoral Scholar
2021 - 2021
Graduate Research Assistant
2016 - 2021
• Investigated the role of lymphatic vessels in regulating anti-tumor immunity in breast cancer • Contributed to development of various engineered immunotherapies in cancer and autoimmunity
Analyst Intern
2019 - 2020
Researched competitive companies and underlying markets in the food/peanut allergy space; advised on designing IND-enabling studies
ClostraBio is a biopharma company developing therapeutics for food allergies.
Raised $7,540,000.00 from Portal Innovations.
Investment Analyst Intern
2019 - 2019
ARCH is a venture firm that focuses on life science discoveries to prevent, detect, and cure disease.
Technology Venture Associate
2018 - 2019
Performed market and competitive analysis for early-stage startups; helped to raise $200K of seed funding for an oncology diagnostic startup
UChicagoTech launched the Innovation Fund in 2010 to accelerate the commercialization of promising.
Biotechnology Analyst Intern
2018 - 2018
Performed due diligence on public biotechs (small/mid cap) to evaluate investment opportunities in immuno-oncology and rare diseases
Aspire Capital Partners LLC is a Chicago-based investment fund with a focus on making direct investments in publicly traded companies in a